Goldman Sachs Sticks to Their Hold Rating for Novartis AG (NOVN)
In a report released today, James Quigley from Goldman Sachs maintained a Hold rating on Novartis AG (NOVN – Research Report), with a price ...
Novartis AG (NVS): Among the Best Foreign Dividend Stocks to Invest In Now
We recently compiled a list of the 10 Best Foreign Stocks With Dividends For Passive Income. In this article, we are going to ...
DAVENPORT & Co LLC Sells 1,118 Shares of Novartis AG (NYSE:NVS)
DAVENPORT & Co LLC reduced its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 3.3% in the fourth quarter, ...
2,388 Shares in Novartis AG (NYSE:NVS) Acquired by Chicago Partners Investment Group LLC
Chicago Partners Investment Group LLC bought a new stake in shares of Novartis AG (NYSE:NVS – Free Report) during the 4th ...
Novartis's SWOT analysis: pharma giant's stock navigates generic headwinds
Novartis AG (NYSE:NVS), a global healthcare powerhouse with a market capitalization of $208.27 billion, has recently transformed into a pure-play pharmaceutical company, sharpening its focus on its ...
Novartis AG (NOVN) Gets a Buy from UBS
UBS analyst Matthew Weston maintained a Buy rating on Novartis AG (NOVN – Research Report) today and set a price target of CHF111.00.Maximize ...
Novartis has cash for a big pharma deal—but here’s why it’s not buying
Novartis chief executive says large pharma deals usually don't pay off. But the company remains interested in bolt-on ...
Novartis Q4 Earnings: Revenue And EPS Beat, CEO Dismisses Entresto Patent Expiration Worries
Novartis reported strong Q4 earnings and sales growth, with CEO Narasimhan reportedly downplaying concerns over Entresto's ...